429 related articles for article (PubMed ID: 28814098)
1. Quantitative and qualitative MRI evaluation of cerebral small vessel disease in an elderly population: a longitudinal study.
Nylander R; Fahlström M; Rostrup E; Kullberg J; Damangir S; Ahlström H; Lind L; Larsson EM
Acta Radiol; 2018 May; 59(5):612-618. PubMed ID: 28814098
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.
van der Veen PH; Muller M; Vincken KL; Hendrikse J; Mali WP; van der Graaf Y; Geerlings MI;
Stroke; 2015 May; 46(5):1233-8. PubMed ID: 25804924
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
[TBL] [Abstract][Full Text] [Related]
4. MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
Uiterwijk R; Staals J; Huijts M; de Leeuw PW; Kroon AA; van Oostenbrugge RJ
J Hypertens; 2017 Jun; 35(6):1263-1270. PubMed ID: 28169884
[TBL] [Abstract][Full Text] [Related]
5. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
[TBL] [Abstract][Full Text] [Related]
6. Contribution of acute infarcts to cerebral small vessel disease progression.
Ter Telgte A; Wiegertjes K; Gesierich B; Marques JP; Huebner M; de Klerk JJ; Schreuder FHBM; Araque Caballero MA; Kuijf HJ; Norris DG; Klijn CJM; Dichgans M; Tuladhar AM; Duering M; de Leeuw FE
Ann Neurol; 2019 Oct; 86(4):582-592. PubMed ID: 31340067
[TBL] [Abstract][Full Text] [Related]
7. Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up.
Cai M; Jacob MA; van Loenen MR; Bergkamp M; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
Stroke; 2022 Sep; 53(9):2789-2798. PubMed ID: 35506383
[TBL] [Abstract][Full Text] [Related]
8. The role of small diffusion-weighted imaging lesions in cerebral small vessel disease.
Wiegertjes K; Ter Telgte A; Oliveira PB; van Leijsen EMC; Bergkamp MI; van Uden IWM; Ghafoorian M; van der Holst HM; Norris DG; Platel B; Klijn CJM; Tuladhar AM; de Leeuw FE
Neurology; 2019 Oct; 93(17):e1627-e1634. PubMed ID: 31530710
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
[TBL] [Abstract][Full Text] [Related]
11. The association between lacunes and white matter hyperintensity features on MRI: The SMART-MR study.
Ghaznawi R; Geerlings MI; Jaarsma-Coes MG; Zwartbol MH; Kuijf HJ; van der Graaf Y; Witkamp TD; Hendrikse J; de Bresser J
J Cereb Blood Flow Metab; 2019 Dec; 39(12):2486-2496. PubMed ID: 30204039
[TBL] [Abstract][Full Text] [Related]
12. A typology of cerebral small vessel disease based on imaging markers.
Sperber C; Hakim A; Gallucci L; Seiffge D; Rezny-Kasprzak B; Jäger E; Meinel T; Wiest R; Fischer U; Arnold M; Umarova R
J Neurol; 2023 Oct; 270(10):4985-4994. PubMed ID: 37368130
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.
van Leijsen EMC; van Uden IWM; Ghafoorian M; Bergkamp MI; Lohner V; Kooijmans ECM; van der Holst HM; Tuladhar AM; Norris DG; van Dijk EJ; Rutten-Jacobs LCA; Platel B; Klijn CJM; de Leeuw FE
Neurology; 2017 Oct; 89(15):1569-1577. PubMed ID: 28878046
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
Front Immunol; 2021; 12():803504. PubMed ID: 34956241
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.
Rudilosso S; Stringer MS; Thrippleton M; Chappell F; Blair GW; Jaime Garcia D; Doubal F; Hamilton I; Janssen E; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; Duering M; Dichgans M; Wardlaw JM;
J Cereb Blood Flow Metab; 2023 Sep; 43(9):1490-1502. PubMed ID: 37132279
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.
Gyanwali B; Shaik MA; Tan BY; Venketasubramanian N; Chen C; Hilal S
J Alzheimers Dis; 2019; 67(4):1209-1219. PubMed ID: 30714960
[TBL] [Abstract][Full Text] [Related]
17. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
[TBL] [Abstract][Full Text] [Related]
18. Association of neuroimaging markers of cerebral small vessel disease with short-term outcomes in patients with minor cerebrovascular events.
Chen X; Wang L; Jiang J; Gao Y; Zhang R; Zhao X; Shen T; Dai Q; Li J
BMC Neurol; 2021 Jan; 21(1):21. PubMed ID: 33441129
[TBL] [Abstract][Full Text] [Related]
19. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries.
Hilal S; Mok V; Youn YC; Wong A; Ikram MK; Chen CL
J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):669-674. PubMed ID: 28600443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
